chinese anti - cancer association ( uscaca ,  ) ( http://www.uscaca.org/ ) is a non - profit professional organiza - tion founded in 2009 . with members from academia , industry and government , uscaca facilitates collaboration among cancer research and physicians in the united states and china . our current focus is on expediting novel cancer drug development by fostering clinical trial networks , sharing best practices and knowledge of clinical trial , and providing education and training opportunities . uscaca collaborates with chinese anti - cancer association ( caca ,  ) , chinese society for clinical oncology ( csco ) , and other professional associations . yun - guang tong , cedars - sinai medical center / ucla school of medicine michael shi , novartis oncology shi - yuan cheng , northwestern university li yan , peking university and glaxosmithkline roger luo , janssen pharmaceutical co. li - fang hou , northwestern university wei zhang , university of illinois at chicago wei - min qi , biocare medical wei zhang , md anderson cancer center li xu , jiangsu hengrui oncology pascal qian , novartis oncology xiao - xiang chen , boehringer - ingelheim wan - cai yang , xinxiang medical university yun dai , virginia commonwealth university
the 6th annual meeting of the united states chinese anti - cancer association ( uscaca ) was held in conjunction with the 50th annual meeting of american society of clinical oncology ( asco ) on may 30 , 2014 in chicago , illinois , the united states of america . with a focus on personalized medicine , 
 the conference featured novel approaches to investigate genomic aberrations in cancer cells and innovative clinical trial designs to expedite cancer drug development in biomarker - defined patient populations . a panel discussion further provided in - depth advice on advancing development of personalized cancer medicines in china . 
 the conference also summarized uscaca key initiatives and accomplishments , including two awards designated to recognize young investigators from china for their achievements and to support their training in the united states . 
 as an effort to promote international collaboration , uscaca will team up with chinese society of clinical oncology ( csco ) to host a joint session on  breakthrough cancer medicines  at the upcoming csco annual meeting on september 20th , 2014 in xiamen , china .